Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

TRMK vs BMA: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

TRMK Wins Head-to-Head Institutional Verdict (3–2 across 6 Pillars · 7–3 Matrix Metrics)

TRMK Overall Winner 6-Pillar Tally: TRMK 3 – 2 BMA (1 Tie) Matrix Metrics: TRMK 7 – 3 BMA

As of Nov 16, 2026, Trustmark Corp (TRMK) is the stronger overall head-to-head candidate over Banco Macro S.A. (BMA) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). TRMK carries a Unified Composite Score of 48.3/100 (HOLD) at $47.63 (11.2x Forward P/E, 35.1% operating margin), whereas BMA carries 39.3/100 (SELL) at $53.85 (3.1x Forward P/E, 18.0% operating margin).

  • Technical & Structure Timing Caution: TRMK trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 61.6); meanwhile BMA is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 30.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About TRMK vs BMA
TRMK NASDAQ Head-to-Head Winner
Trustmark Corp
National Commercial Banks
$47.63
-0.52% 1D
Market Cap $2.8B
TTM Revenue $819M
Forward P/E 11.2x
Beta / 30D Vol 0.29β · 27% Vol
Unified Composite Score
48.3 / 100 HOLD
Tech 51.0 Fund 44.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 62
RSI-14: 61.6 · SMA20: $45.73 · SMA50: $45.68
BMA NYSE
Banco Macro S.A.
Commercial Banks, Nec
$53.85
-5.29% 1D
Market Cap $3.6B
TTM Revenue $3.48B
Forward P/E 3.1x
Beta / 30D Vol 1.42β · 42% Vol
Unified Composite Score
39.3 / 100 SELL
Tech 29.0 Fund 45.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -9.8%), weak momentum, RSI 31
RSI-14: 30.7 · SMA20: $59.84 · SMA50: $66.06

6-Pillar Scorecard Institutional Category Breakdown (TRMK 3 – 2 BMA)

Columns: Metric · TRMK · BMA
1. Valuation Multiples BMA
Forward P/E 11.2x 3.1x
Trailing P/E 12.0x 11.4x
PEG Ratio 2.29x 0.47x
EV / Revenue 3.4x 1.0x
2. Growth & Scale TRMK
Revenue Growth (YoY) +2.1% +1.2%
Earnings Growth (YoY) +6.4% +3.5%
TTM Revenue (USD) $819M $3.48B
Market Cap $2.8B $3.6B
3. Profitability & Quality TRMK
Gross Margin 100.0% 98.7%
Operating Margin 35.1% 18.0%
Net Profit Margin 28.7% 9.0%
Return on Equity (ROE) 11.2% 7.1%
4. Balance Sheet & Cash Flow TRMK
Cash Generation (TTM) N/A N/A
Cash Flow Margin N/A N/A
Net Cash / Leverage $36.21 Book/Sh · 11.2% ROE $64.45 Book/Sh · 7.1% ROE
Dividend Yield 2.17% None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile 174.6% (100th %ile) 77.3% (51st %ile)
Put/Call OI Skew N/A Thin ADR Chain
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Markdown
6. R&D & Supply-Chain Moat BMA
OpEx & R&D Intensity 64.9% of Rev ($532M) 80.7% of Rev ($2.81B)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat High-Margin Pricing Power Moat Scale & Operating Efficiency Moat
Supply-Chain Role Banks - Regional Operator Banks - Regional Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: TRMK (7) vs BMA (3)
Institutional Metric TRMK BMA Criterion Row Edge
Market Capitalization
Scale
$2.8B $3.6B Larger Scale BMA
Trailing P/E Ratio
Valuation
12.0x 11.4x Lower Multiple BMA
Forward P/E Ratio
Valuation
11.2x 3.1x Lower Multiple BMA
Revenue Growth (YoY)
Growth
+2.1% +1.2% Higher Growth TRMK
Operating Margin (TTM)
Profitability
35.1% 18.0% Higher Margin TRMK
Net Profit Margin
Profitability
28.7% 9.0% Higher Margin TRMK
Return on Equity (ROE)
Capital Efficiency
11.2% 7.1% Higher ROE TRMK
52-Week Range Position
Momentum
89% ($36–$49) 0% ($54–$106) Stronger Trend TRMK
Beta / 30D Volatility
Risk Regime
0.29β · 27% Vol 1.42β · 42% Vol Lower Realized Risk TRMK
Unified Institutional Score
Composite Signal
48.3 / 100 (HOLD) 39.3 / 100 (SELL) Higher Composite TRMK
Trailing 12M Revenue (USD)
Operating Scale
$819M $3.48B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
100.0% 98.7% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
2.29x PEG · 3.4x EV/Rev 0.47x PEG · 1.0x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A ($36.21 Book/Sh · 11.2% ROE) N/A ($64.45 Book/Sh · 7.1% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon TRMK +21.99 pp
TRMK: +6.08% · BMA: -15.91%
3M Horizon TRMK +29.09 pp
TRMK: -0.13% · BMA: -29.22%
6M Horizon TRMK +34.28 pp
TRMK: +8.47% · BMA: -25.81%
1Y Horizon TRMK +60.02 pp
TRMK: +24.78% · BMA: -35.24%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on TRMK vs BMA. Trailing 12-month operating profitability (TRMK 35.1% vs BMA 18.0%) and valuation multiples (TRMK 11.2x vs BMA 3.1x Forward P/E) are benchmarked directly in Pillar 4 below.

TRMK ADR TTM Benchmark FX-Normalized USD
TTM Revenue$819M
Gross Margin100.0%
Op. Margin35.1%
ROE / Fwd P/E11.2% · 11.2x
BMA ADR TTM Benchmark FX-Normalized USD
TTM Revenue$3.48B
Gross Margin98.7%
Op. Margin18.0%
ROE / Fwd P/E7.1% · 3.1x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
TRMK UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 174.6%
IV Percentile 100th %ile
Put/Call OI Skew N/A
IV Regime Extreme (>80th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact TRMK Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
BMA UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 77.3%
IV Percentile 51st %ile
Put/Call OI Skew Thin ADR Chain
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact BMA Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
TRMK Moat Profile High-Margin Pricing Power Moat
Banks - Regional Operator
Competes within the Banks - Regional value chain with $2.8B market capitalization and 35.1% operating margin.
OpEx & R&D Reinvestment 64.9% of Rev ($532M)
90D Engineering Disclosures 0 Published
BMA Moat Profile Scale & Operating Efficiency Moat
Banks - Regional Operator
Competes within the Banks - Regional value chain with $3.6B market capitalization and 18.0% operating margin.
OpEx & R&D Reinvestment 80.7% of Rev ($2.81B)
90D Engineering Disclosures 0 Published

Investor FAQ TRMK vs BMA Key Questions & Quantitative Answers

As of Nov 16, 2026, Trustmark Corp (TRMK) is the stronger overall head-to-head candidate over Banco Macro S.A. (BMA) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). TRMK carries a Unified Composite Score of 48.3/100 (HOLD) at $47.63 (11.2x Forward P/E, 35.1% operating margin), whereas BMA carries 39.3/100 (SELL) at $53.85 (3.1x Forward P/E, 18.0% operating margin). Technical & Structure Timing Caution: TRMK trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 61.6); meanwhile BMA is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 30.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

TRMK leads the Growth & Scale pillar: TRMK posts +2.1% YoY revenue growth and +6.4% YoY earnings growth on $819M TTM revenue (100.0% gross margin, 35.1% operating margin), compared with BMA at +1.2% YoY revenue growth and +3.5% YoY earnings growth on $3.48B TTM revenue (98.7% gross margin, 18.0% operating margin). On trailing 12-month operating scale, TRMK generates $819M in USD-normalized revenue versus $3.48B for BMA. In operating R&D and SG&A reinvestment, TRMK deploys 64.9% of Rev ($532M) (0 90-day corporate R&D disclosures) versus 80.7% of Rev ($2.81B) (0 disclosures) for BMA.

BMA screens cheaper on headline valuation multiples. TRMK trades at 11.2x Forward P/E, 12.0x Trailing P/E, 2.29x PEG, and 3.4x EV/Revenue (unreported cash flow margin), whereas BMA trades at 3.1x Forward P/E, 11.4x Trailing P/E, 0.47x PEG, and 1.0x EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against TRMK (11.2% ROE) versus BMA (7.1% ROE) capital efficiency.

In options market volatility and institutional positioning, TRMK carries 174.6% implied volatility (100th %ile, Extreme (>80th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.29β · 27% Vol realized risk). By comparison, BMA carries 77.3% implied volatility (51st %ile, Balanced (25th–60th %ile)), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.42β · 42% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.